Page 33 - Michael Erman News Today

(Reuters) -Updated COVID-19 vaccine boosters need to target one of the currently dominant XBB variants during the 2023-2024 vaccination campaign, the ...

(Reuters) -Updated COVID-19 vaccine boosters need to target one of the currently dominant XBB variants during the 2023-2024 vaccination campaign, the ...

The U.S. Food and Drug Administration said on Friday it is seeking new suppliers to ease shortages of methotrexate, one of the most commonly used cancer drugs, building on its push to shore up two... | June 9, 2023

(This May 31 story has been corrected to fix the spelling of executive's name to Teresa, not Theresa, in paragraph 5) | 08:32pm

(Removes extraneous word in paragraph 9) By Michael Erman (Reuters) - Novavax Incs head of research and development on Monday said an updated ...

By Michael Erman

Novavaxs head of research and development said an updated vaccine the company is already producing is likely to be protective against other fast-growing coronavirus variants circulating in the US.

NEW YORK -Merck & Co sued the U.S. government on Tuesday, seeking to halt the Medicare drug price negotiation program contained in the Inflation Reduction Act , which it argues violates the Fifth... | June 10, 2023

NEW YORK (Reuters) -Merck & Co sued the U.S. government on Tuesday, seeking to halt the Medicare drug price negotiation program contained in the Inflation Reduction Act (IRA), which it argues violates the Fifth and First Amendments to the U.S. Constitution. This is the first attempt by a drugmaker to challenge the law, which the pharmaceutical industry says will result in a loss of profits that will force them to pull back on developing groundbreaking new treatments. The Biden administration...

(Removes extraneous word in paragraph 9) By Michael Erman (Reuters) - Novavax Inc's head of research and development on Monday said an updated COVID-1...